Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting.
Adult
Aged
Dentistry
Diabetes Mellitus, Type 2
/ prevention & control
Early Medical Intervention
/ methods
Female
Humans
Hypertension
/ prevention & control
Male
Middle Aged
Noncommunicable Diseases
/ prevention & control
Patient Acceptance of Health Care
Pharmacies
Point-of-Care Testing
Pulmonary Disease, Chronic Obstructive
/ prevention & control
Renal Insufficiency, Chronic
/ prevention & control
United Kingdom
/ epidemiology
Vitamin D Deficiency
/ prevention & control
Dental
Non-communicable diseases
Pharmacy
Prevention
Screening
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
20 Oct 2020
20 Oct 2020
Historique:
received:
31
01
2020
accepted:
07
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
20
1
2021
Statut:
epublish
Résumé
Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals' access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12 months. The objectives of this study were to determine: whether NCD case finding in dental/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone. An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients > 40 years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine/eGFR, Vitamin-D. Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10 cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants. Recruitment rates demonstrated that 8 days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease. Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients.
Sections du résumé
BACKGROUND
BACKGROUND
Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals' access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12 months. The objectives of this study were to determine: whether NCD case finding in dental/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone.
METHODS
METHODS
An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients > 40 years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine/eGFR, Vitamin-D. Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10 cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants.
RESULTS
RESULTS
Recruitment rates demonstrated that 8 days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease.
CONCLUSIONS
CONCLUSIONS
Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients.
Identifiants
pubmed: 33081745
doi: 10.1186/s12889-020-09649-7
pii: 10.1186/s12889-020-09649-7
pmc: PMC7576866
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1576Subventions
Organisme : Oral and Dental Research Trust (GB)
ID : -
Commentaires et corrections
Type : ErratumIn
Références
National Council on Aging. [18th June 2020]; Available from: https://www.ncoa.org/news/resources-for-reporters/get-the-facts/healthy-aging-facts/?print=t .
Scarborough P, Bhatnagar P, Wickramasinghe KK, Allender S, Foster C, Rayner M. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs. J Public Health. 2011;33(4):527–35.
doi: 10.1093/pubmed/fdr033
Yonel Z, Sharma P, Yahyouche A, Jalal Z, Dietrich T, Chapple IL. Patients’ attendance patterns to different healthcare settings and perceptions of stakeholders regarding screening for chronic, non-communicable diseases in high street dental practices and community pharmacy: a cross-sectional study. BMJ Open. 2018;8(11):e024503. https://doi.org/10.1136/bmjopen-2018-024503 . PMID: 30391921; PMCID: PMC6231598.
Estrich C, Araujo MWB, Lipman R. Prediabetes and Diabetes screening in dental care settings: NHANES 2013 to 2016. JDR Clin Trans Res. 2019;4(1):76–85.
pubmed: 30596147
Strauss SM, Russell S, Wheeler A, Norman R, Borrell LN, Rindskopf D. The dental office visit as a potential opportunity for diabetes screening: an analysis using NHANES 2003-2004 data. J Public Health Dent. 2010;70(2):156–62.
pubmed: 20002875
White DA, Tsakos G, Pitts NB, Fuller E, Douglas GVA, Murray JJ, et al. Adult dental health survey 2009: common oral health conditions and their impact on the population. Br Dent J. 2012;213(11):567–72.
doi: 10.1038/sj.bdj.2012.1088
Wiedenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M, Tromp D, et al. Developing pharmacy practice : a focus on patient care : handbook. Geneva : World Health Organization: WHO; 2006.
Smith J, Picton C and Dayan M (2014) Now more than ever: why pharmacy needs to act. [June 18, 2020] Available from: https://www.nuffieldtrust.org.uk/research/now-more-than-ever-why-pharmacy-needs-to-act .
NHS England. Five year forward view. 2014. [June, 18
Roland M. The future of Primary Care: creating teams for tomorrow. Leeds: Health Education England. Primary Care Workforce Commission: 2015. [June, 18
National Instititute for Health and Care Excellence. NICE Public Health Guidance [PH38] type 2 diabetes: prevention in people at high risk. 2017. Webpage. [June 18
Sanz M, Ceriello A, Buysschaert M, Chapple IL, Demmer RT, Graziani F, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and by the international Diabetes federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231–41.
doi: 10.1016/j.diabres.2017.12.001
Public Health England NEaHEE. Pharmacy: A Way Forward for Public Health. Opportunities for action through pharmacy for public health. Public Health England: 2017 Acessed: [June 6
Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: a systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29–38.
doi: 10.1111/bcp.14164
Sicard DA, Taylor JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39(6):1024–8.
doi: 10.1345/aph.1E504
Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011;135(11):1405–14.
doi: 10.5858/arpa.2011-0157-RA
Cals JW, Schols AM, van Weert HC, Stevens F, Zeijen CG, Holtman G, et al. Point-of-care testing in family practices: present use and need for tests in the future. Nederlands tijdschrift voor geneeskunde, 2014;158:A8210.
Briggs C, Guthrie D, Hyde K, Mackie I, Parker N, Popek M, et al. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008;142(6):904–15.
doi: 10.1111/j.1365-2141.2008.07274.x
Stone MA, Burden AC, Burden M, Baker R, Khunti K. Near patient testing for glycated haemoglobin in people with type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med. 2007;24(7):792–5.
doi: 10.1111/j.1464-5491.2007.02175.x
Delaney B, Wilson S, Fitzmaurice D, Hyde C, Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Pol. 2000;5(1):37–41.
doi: 10.1177/135581960000500109
Diabetes UK, the University of Leicester and the University Hospital of Leicester NHS Trust. Diabetes Risk Score. Diabetes UK, the University of Leicester and the University Hospital of Leicester NHS Trust; [25/09/2020]; Available from: https://riskscore.diabetes.org.uk/start .
Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D’Eletto T, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD: Int J Chron Obstruct Pulmon Dis. 2008;5(2):85–95.
doi: 10.1080/15412550801940721
Genco RJ, Schifferle RE, Dunford RG, Falkner KL, Hsu WC, Balukjian J. Screening for diabetes mellitus in dental practices a field trial. JADA. 2014;145(1):57–64.
pubmed: 24379330
Lalla E, Cheng B, Kunzel C, Burkett S, Ferraro A, Lamster IB. Six-month outcomes in dental patients identified with hyperglycaemia: a randomized clinical trial. J Clin Periodontol. 2015;42(3):228–35.
doi: 10.1111/jcpe.12358
Creanor S, Millward BA, Demaine A, Price L, Smith W, Brown N, et al. Patients' attitudes towards screening for diabetes and other medical conditions in the dental setting. Br Dent J. 2014;216(1):E2.
doi: 10.1038/sj.bdj.2013.1247
Yonel Z, Cerullo E, Kröger AT, Gray LJ. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review. Diabet Med. 2020;19.
Yonel Z, Batt J, Jane R, Cerullo E, Gray LJ, Dietrich T, et al. The Role of the Oral Healthcare Team in Identification of Type 2 Diabetes Mellitus: A Systematic Review. Curr. Oral Health Rep. 2020 2020/01/18.
Bould K, Scott SE, Dunne S, Asimakopoulou K. Uptake of screening for type 2 diabetes risk in general dental practice; an exploratory study. Br. Dent.. 2017 02/24/online;222:293.
Public Health England NEaHEE. Public Health Matters. 2020 [June 6
NHS. Longterm Plan. [June 6
National Instititute for Health and Care Excellence. NICE Public Health Guidance [PH38] type 2 diabetes: Encouraging people to have a risk-assessment for type 2 diabetes and identifying those at risk. 2017. [June 6
Waugh NR, Shyangdan, D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technology Assessment (Winchester, England), Volume 17 (Number 35). pp. 1–90.